• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

机器学习患者特征预测未确诊疾病网络中的入院结局。

Machine Learning of Patient Characteristics to Predict Admission Outcomes in the Undiagnosed Diseases Network.

机构信息

Department of Biomedical Informatics, Harvard University, Boston, Massachusetts.

Department of Computer Science, University of Massachusetts, Lowell.

出版信息

JAMA Netw Open. 2021 Feb 1;4(2):e2036220. doi: 10.1001/jamanetworkopen.2020.36220.

DOI:10.1001/jamanetworkopen.2020.36220
PMID:33630084
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7907957/
Abstract

IMPORTANCE

The Undiagnosed Diseases Network (UDN) is a national network that evaluates individual patients whose signs and symptoms have been refractory to diagnosis. Providing reliable estimates of admission outcomes may assist clinical evaluators to distinguish, prioritize, and accelerate admission to the UDN for patients with undiagnosed diseases.

OBJECTIVE

To develop computational models that effectively predict admission outcomes for applicants seeking UDN evaluation and to rank the applications based on the likelihood of patient admission to the UDN.

DESIGN, SETTING, AND PARTICIPANTS: This prognostic study included all applications submitted to the UDN from July 2014 to June 2019, with 1209 applications accepted and 1212 applications not accepted. The main inclusion criterion was an undiagnosed condition despite thorough evaluation by a health care professional; the main exclusion criteria were a diagnosis that explained the objective findings or a review of the records that suggested a diagnosis. A classifier was trained using information extracted from application forms, referral letters from health care professionals, and semantic similarity between referral letters and textual description of known mendelian disorders. The admission labels were provided by the case review committee of the UDN. In addition to retrospective analysis, the classifier was prospectively tested on another 288 applications that were not evaluated at the time of classifier development.

MAIN OUTCOMES AND MEASURES

The primary outcomes were whether a patient was accepted or not accepted to the UDN and application order ranked based on likelihood of admission. The performance of the classifier was assessed by comparing its predictions against the UDN admission outcomes and by measuring improvement in the mean processing time for accepted applications.

RESULTS

The best classifier obtained sensitivity of 0.843, specificity of 0.738, and area under the receiver operating characteristic curve of 0.844 for predicting admission outcomes among 1212 accepted and 1210 not accepted applications. In addition, the classifier can decrease the current mean (SD) UDN processing time for accepted applications from 3.29 (3.17) months to 1.05 (3.82) months (68% improvement) by ordering applications based on their likelihood of acceptance.

CONCLUSIONS AND RELEVANCE

A classification system was developed that may assist clinical evaluators to distinguish, prioritize, and accelerate admission to the UDN for patients with undiagnosed diseases. Accelerating the admission process may improve the diagnostic journeys for these patients and serve as a model for partial automation of triaging or referral for other resource-constrained applications. Such classification models make explicit some of the considerations that currently inform the use of whole-genome sequencing for undiagnosed disease and thereby invite a broader discussion in the clinical genetics community.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dac1/7907957/1b44357b0731/jamanetwopen-e2036220-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dac1/7907957/6a519f8424f6/jamanetwopen-e2036220-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dac1/7907957/1b44357b0731/jamanetwopen-e2036220-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dac1/7907957/6a519f8424f6/jamanetwopen-e2036220-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dac1/7907957/1b44357b0731/jamanetwopen-e2036220-g002.jpg
摘要

重要性

未确诊疾病网络(UDN)是一个全国性的网络,用于评估那些症状和体征难以确诊的个体患者。提供可靠的入院结果估计可能有助于临床评估人员区分、优先考虑并加快患有未确诊疾病的患者进入 UDN。

目的

开发能够有效预测申请 UDN 评估的患者入院结果的计算模型,并根据患者进入 UDN 的可能性对申请进行排名。

设计、环境和参与者:这项预后研究纳入了 2014 年 7 月至 2019 年 6 月期间向 UDN 提交的所有申请,共纳入 1209 份接受申请和 1212 份不接受申请。主要纳入标准是尽管经过医疗保健专业人员的全面评估仍未确诊的疾病;主要排除标准是诊断可以解释客观发现或审查记录提示诊断。使用从申请表中提取的信息、医疗保健专业人员的转诊信以及转诊信与已知孟德尔疾病文本描述之间的语义相似性来训练分类器。入院标签由 UDN 的病例审查委员会提供。除了回顾性分析外,该分类器还前瞻性地测试了另外 288 份在分类器开发时未进行评估的申请。

主要结果和措施

主要结果是患者是否被 UDN 接受或拒绝,以及根据入院可能性对申请进行排名。通过将预测结果与 UDN 入院结果进行比较,并通过衡量接受申请的平均处理时间的改善来评估分类器的性能。

结果

在 1212 份接受申请和 1210 份不接受申请中,最佳分类器预测入院结果的敏感性为 0.843,特异性为 0.738,受试者工作特征曲线下面积为 0.844。此外,通过根据接受申请的可能性对申请进行排序,该分类器可将当前 UDN 接受申请的平均(SD)处理时间从 3.29(3.17)个月减少到 1.05(3.82)个月(提高 68%)。

结论和相关性

开发了一种分类系统,可帮助临床评估人员区分、优先考虑并加快患有未确诊疾病的患者进入 UDN。加快入院流程可以改善这些患者的诊断之旅,并为其他资源受限的申请的分诊或转诊的部分自动化提供模型。这种分类模型明确了一些目前用于未确诊疾病的全基因组测序的考虑因素,从而在临床遗传学社区引发了更广泛的讨论。

相似文献

1
Machine Learning of Patient Characteristics to Predict Admission Outcomes in the Undiagnosed Diseases Network.机器学习患者特征预测未确诊疾病网络中的入院结局。
JAMA Netw Open. 2021 Feb 1;4(2):e2036220. doi: 10.1001/jamanetworkopen.2020.36220.
2
Characteristics of undiagnosed diseases network applicants: implications for referring providers.未确诊疾病网络申请者的特征:对转诊医疗机构的启示
BMC Health Serv Res. 2018 Aug 22;18(1):652. doi: 10.1186/s12913-018-3458-2.
3
The Undiagnosed Diseases Network: Characteristics of solvable applicants and diagnostic suggestions for nonaccepted ones.未确诊疾病网络:可确诊患者的特征及未被接受患者的诊断建议。
Genet Med. 2024 Oct;26(10):101203. doi: 10.1016/j.gim.2024.101203. Epub 2024 Jul 2.
4
Identifying digenic disease genes via machine learning in the Undiagnosed Diseases Network.通过机器学习在未确诊疾病网络中鉴定双基因疾病基因。
Am J Hum Genet. 2021 Oct 7;108(10):1946-1963. doi: 10.1016/j.ajhg.2021.08.010. Epub 2021 Sep 15.
5
Reported environmental exposures are inversely associated with obtaining a genetic diagnosis in the Undiagnosed Diseases Network.报道的环境暴露与在未确诊疾病网络中获得基因诊断呈负相关。
Am J Med Genet A. 2019 Jun;179(6):958-965. doi: 10.1002/ajmg.a.61132. Epub 2019 Mar 23.
6
Undiagnosed Disease Network collaborative approach in diagnosing rare disease in a patient with a mosaic CACNA1D variant.采用未确诊疾病网络协作方法诊断携带 CACNA1D 嵌合体变异患者的罕见病。
Am J Med Genet A. 2024 Jul;194(7):e63597. doi: 10.1002/ajmg.a.63597. Epub 2024 Mar 21.
7
Participation in a national diagnostic research study: assessing the patient experience.参与国家诊断研究:评估患者体验。
Orphanet J Rare Dis. 2023 Apr 10;18(1):73. doi: 10.1186/s13023-023-02695-5.
8
Clinical sites of the Undiagnosed Diseases Network: unique contributions to genomic medicine and science.未确诊疾病网络的临床站点:对基因组医学和科学的独特贡献。
Genet Med. 2021 Feb;23(2):259-271. doi: 10.1038/s41436-020-00984-z. Epub 2020 Oct 23.
9
Effect of Genetic Diagnosis on Patients with Previously Undiagnosed Disease.遗传诊断对先前未确诊疾病患者的影响。
N Engl J Med. 2018 Nov 29;379(22):2131-2139. doi: 10.1056/NEJMoa1714458. Epub 2018 Oct 10.
10
Limitations of exome sequencing in detecting rare and undiagnosed diseases.外显子组测序在检测罕见病和不明原因疾病方面的局限性。
Am J Med Genet A. 2020 Jun;182(6):1400-1406. doi: 10.1002/ajmg.a.61558. Epub 2020 Mar 19.

引用本文的文献

1
Integration of artificial intelligence and multi-omics in kidney diseases.人工智能与多组学在肾脏疾病中的整合
Fundam Res. 2022 Mar 16;3(1):126-148. doi: 10.1016/j.fmre.2022.01.037. eCollection 2023 Jan.

本文引用的文献

1
SciPy 1.0: fundamental algorithms for scientific computing in Python.SciPy 1.0:Python 中的科学计算基础算法。
Nat Methods. 2020 Mar;17(3):261-272. doi: 10.1038/s41592-019-0686-2. Epub 2020 Feb 3.
2
Effect of Genetic Diagnosis on Patients with Previously Undiagnosed Disease.遗传诊断对先前未确诊疾病患者的影响。
N Engl J Med. 2018 Nov 29;379(22):2131-2139. doi: 10.1056/NEJMoa1714458. Epub 2018 Oct 10.
3
Characteristics of undiagnosed diseases network applicants: implications for referring providers.未确诊疾病网络申请者的特征:对转诊医疗机构的启示
BMC Health Serv Res. 2018 Aug 22;18(1):652. doi: 10.1186/s12913-018-3458-2.
4
The Undiagnosed Diseases Network: Accelerating Discovery about Health and Disease.未确诊疾病网络:加速健康与疾病的发现。
Am J Hum Genet. 2017 Feb 2;100(2):185-192. doi: 10.1016/j.ajhg.2017.01.006.
5
The Undiagnosed Diseases Network of the National Institutes of Health: A National Extension.美国国立卫生研究院未确诊疾病网络:一项全国性扩展计划。
JAMA. 2015 Nov 3;314(17):1797-8. doi: 10.1001/jama.2015.12249.
6
The Genetic Basis of Mendelian Phenotypes: Discoveries, Challenges, and Opportunities.孟德尔表型的遗传基础:发现、挑战与机遇
Am J Hum Genet. 2015 Aug 6;97(2):199-215. doi: 10.1016/j.ajhg.2015.06.009. Epub 2015 Jul 9.
7
Somatoform disorders and medically unexplained symptoms in primary care.基层医疗中的躯体形式障碍和医学上无法解释的症状。
Dtsch Arztebl Int. 2015 Apr 17;112(16):279-87. doi: 10.3238/arztebl.2015.0279.
8
Classification and codification of rare diseases.罕见病的分类与编码
J Clin Epidemiol. 2012 Sep;65(9):1026-7. doi: 10.1016/j.jclinepi.2012.02.014. Epub 2012 Apr 20.
9
Rare diseases and orphan drugs.罕见病和孤儿药。
Ann Ist Super Sanita. 2011;47(1):83-93. doi: 10.4415/ANN_11_01_17.
10
Why rare diseases are an important medical and social issue.为什么罕见病是一个重要的医学和社会问题。
Lancet. 2008 Jun 14;371(9629):2039-41. doi: 10.1016/S0140-6736(08)60872-7.